LWB.L Regulatory News (LWB)

LEI213800CALFKOEL7N7P10

Low & Bonar PLC

Appointment of Group Chief Executive Officer

Low & Bonar PLC ("Low & Bonar" or the "Group"), the international performance materials group, is pleased to announce the appointment of Philip de Klerk as Group Chief Executive Officer with effect from 1 March 2018.

Philip will succeed Trudy Schoolenberg who was appointed Interim Group Chief Executive Officer on 20 December 2017. After handing over to Philip, Trudy has agreed to lead the restructuring of the global supply chain to ensure it meets the needs of the future organisational structure. She will revert to being a Non-Executive Director at the end of April 2018.

Philip joined Low & Bonar as Group Chief Financial Officer in October 2017 and he brings to his new role a depth and breadth of senior executive experience with international companies including Unilever, SAB Miller, Ineos and Flybe.

The Board has set out very clear areas of immediate focus for the Group and is confident that Philip is ideally qualified to execute this agenda effectively and also to lead Low & Bonar on its next stage of profitable growth.

A search for a successor to Philip de Klerk as Group Chief Financial Officer is underway and further announcements will be made in due course.

Martin Flower, Chairman of Low & Bonar, said:

"We are greatly indebted to Trudy for stepping into the breach last month as Interim Group Chief Executive Officer. She has had a very positive impact in a short space of time.

Since joining us last October, Philip has demonstrated very clearly his leadership quality. We are confident that he will execute the Group strategy very effectively and that Low & Bonar will achieve sustained progress under his leadership".

For further information, please contact:

Notes

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation ("MAR") EU no.596/2014. Upon the publication of this announcement via Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.